Analytical Data
-
Gene name
SLC26A9
- Application
-
Alternative Names
Solute carrier family 26 member 9; Anion transporter/exchanger protein 9; SLC26A9; Homo sapiens; Human
-
Species
Human
-
Source
HEK293
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7LBE3-1
-
Expression Region
M1-L791
-
Protein Length
Full Length of Isoform-1
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The SLC26A9 protein, a member of the solute carrier 26 (SLC26) family, is primarily known for its role as an anion exchanger in various epithelial tissues, particularly in the lungs and gastrointestinal tract. Research has shown that SLC26A9 is involved in chloride and bicarbonate transport, which is crucial for maintaining ion balance and pH homeostasis in these tissues. Dysfunction or mutations in SLC26A9 can lead to various pathophysiological conditions, including respiratory diseases and disorders related to intestinal absorption. As a result, understanding the structure and function of SLC26A9 has become essential for elucidating its role in health and disease. Recombinant SLC26A9 proteins provide a valuable tool for investigating the mechanistic aspects of its transport properties, interactions with other cellular components, and potential regulatory mechanisms. Such studies may offer insights into therapeutic strategies for conditions associated with SLC26A9 dysregulation. Given the increasing recognition of the importance of ion transporters in cellular physiology, ongoing research into the characterization and functional analysis of recombinant SLC26A9 proteins is pivotal for both basic science and the development of targeted therapies.
